Reduced water intake deteriorates glucose regulation in patients with type 2 diabetes

Nutrition Research

Volumn 43, Issue , 2017, Pages 25-32

  Johnson, Evan C ^a   Bardis, Costas N ^a   Jansen, Lisa T ^a   Adams, J D ^a   Kirkland, Tracie W ^a   Kavouras, Stavros A ^a,b  

^a UNIVERSITY OF ARKANSAS   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Drinking; Hyperglycemia; Osmolar concentration; Vasopressin

Indexed keywords

GLUCOSE; HYDROCORTISONE; INSULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; DEHYDRATION; FLUID INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PLASMA OSMOLALITY; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINE OSMOLALITY; WATER DEPRIVATION; BLOOD; BODY MASS; DRINKING; GLUCOSE TOLERANCE TEST; HYDRATION STATUS; METABOLISM; OSMOLARITY; PILOT STUDY;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRINKING; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; INSULIN; MALE; MIDDLE AGED; ORGANISM HYDRATION STATUS; OSMOLAR CONCENTRATION; PILOT PROJECTS; RENIN-ANGIOTENSIN SYSTEM;

EID: 85020316379     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2017.05.004     Document Type: Article

References (40)

1. Kant, A.K., Graubard, B.I., Atchison, E.A., Intakes of plain water, moisture in foods and beverages, and total water in the adult US population—nutritional, meal pattern, and body weight correlates: National Health and Nutrition Examination Surveys 1999-2006. Am J Clin Nutr 90 (2009), 655–663.
2. Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D.G., Arthus, M.F., et al. Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats. Diabetologia 58 (2015), 1081–1090.
3. Roussel, R., Fezeu, L., Bouby, N., Balkau, B., Lantieri, O., Alhenc-Gelas, F., et al. Low water intake and risk for new-onset hyperglycemia. Diabetes Care 34 (2011), 2551–2554.
4. Bankir, L., Bardoux, P., Ahloulay, M., Vasopressin and diabetes mellitus. Nephron 87 (2001), 8–18.
5. Enhorning, S., Wang, T.J., Nilsson, P.M., Almgren, P., Hedblad, B., Berglund, G., et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 121 (2010), 2102–2108.
6. Johnson, E.C., Munoz, C.X., Jimenez, L., Le Bellego, L., Kupchak, B.R., Kraemer, W.J., et al. Hormonal and thirst modulated maintenance of fluid balance in young women with different levels of habitual fluid consumption. Nutrients, 8, 2016, 10.3390/nu8050302.
7. Spruce, B.A., McCulloch, A.J., Burd, J., Orskov, H., Heaton, A., Baylis, P.H., et al. The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 22 (1985), 463–468.
8. Kirk, C.J., Rodrigues, L.M., Hems, D.A., The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem J 178 (1979), 493–496.
9. Whitton, P.D., Rodrigues, L.M., Hems, D.A., Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions. Biochem J 176 (1978), 893–898.
10. Perraudin, V., Delarue, C., Lefebvre, H., Contesse, V., Kuhn, J.M., Vaudry, H., Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocrinol Metab 76 (1993), 1522–1528.
11. Rizza, R.A., Mandarino, L.J., Gerich, J.E., Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 54 (1982), 131–138.
12. Melander, O., Vasopressin, from regulator to disease predictor for diabetes and cardiometabolic risk. Ann Nutr Metab 68:Suppl. 2 (2016), 24–28.
13. Underwood, P.C., Adler, G.K., The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 15 (2013), 59–70.
14. Wada, T., Ohshima, S., Fujisawa, E., Koya, D., Tsuneki, H., Sasaoka, T., Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species–mediated pathway in 3T3-L1 adipocytes. Endocrinology 150 (2009), 1662–1669.
15. Lastra, G., Habibi, J., Whaley-Connell, A.T., Manrique, C., Hayden, M.R., Rehmer, J., et al. Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. Endocrinology 150 (2009), 2561–2568.
16. van der Zijl, N.J., Moors, C.C., Goossens, G.H., Hermans, M.M., Blaak, E.E., Diamant, M., Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial. Diabetes Care 34 (2011), 845–851.
17. Zerbe, R.L., Vinicor, F., Robertson, G.L., Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. Am J Physiol 249 (1985), E317–E325.
18. Organization WH, Definition and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes, 1999, World Health Organization.
19. van Loon, L.J.C., Kruijshoop, M., Menheere, P.P.C.A., Wagenmakers, A.J.M., Saris, W.H.M., Keizer, H.A., Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26 (2003), 625–630.
20. Food, Nutrition Board IoM, Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. 2004, National Academies Press, Washington, DC.
21. NCCLS, Procedure for determining packed cell volume by the microhematocrit method; approved standard. NCCLS Document H7-A3, 2000, 1–12.
22. Moore, G.L., Ledford, M.E., Merydith, A., A micromodification of the Drabkin hemoglobin assay for measuring plasma hemoglobin in the range of 5 to 2000 mg/dl. Biochem Med 26 (1981), 167–173.
23. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
24. Katz, A., Nambi, S.S., Mather, K., Baron, A.D., Follmann, D.A., Sullivan, G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000), 2402–2410.
25. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999), 1462–1470.
26. Ballinger, G.A., Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 7 (2004), 127–150.
27. Putnam, K., Shoemaker, R., Yiannikouris, F., Cassis, L.A., The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol 302 (2012), H1219–H1230.
28. Scheen, A.J., Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 64 (2004), 2537–2565.
29. Sowers, J.R., Epstein, M., Frohlich, E.D., Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (Dallas, Tex: 1979) 37 (2001), 1053–1059.
30. Perrier, E., Rondeau, P., Poupin, M., Le Bellego, L., Armstrong, L.E., Lang, F., et al. Relation between urinary hydration biomarkers and total fluid intake in healthy adults. Eur J Clin Nutr 67 (2013), 939–943.
31. Baertschi, A.J., Friedli, M., A novel type of vasopressin receptor on anterior pituitary corticotrophs?. Endocrinology 116 (1985), 499–502.
32. Geer, E.B., Islam, J., Buettner, C., Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am 43 (2014), 75–102.
33. Kam, P.C., Williams, S., Yoong, F.F., Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 59 (2004), 993–1001.
34. Roussel, R., Fezeu, L., Marre, M., Velho, G., Fumeron, F., Jungers, P., et al. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 99 (2014), 4656–4663.
35. Robertson, G.L., Shelton, R.L., Athar, S., The osmoregulation of vasopressin. Kidney Int 10 (1976), 25–37.
36. Burge, M.R., Garcia, N., Qualls, C.R., Schade, D.S., Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metab Clin Exp 50 (2001), 171–177.
37. Fenske, M., Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading. Steroids 71 (2006), 1014–1018.
38. Pickup, J.C., Collins, A.C., Keen, H., Urinary insulin excretion rate: an index of free insulinaemia in insulin-dependent diabetics. Diabet Med 1 (1984), 291–294.
39. American Diabetes A, Standards of medical care in diabetes—2014. Diabetes Care 37:Suppl. 1 (2014), S14–S80.
40. Evert, A.B., Boucher, J.L., Cypress, M., Dunbar, S.A., Franz, M.J., Mayer-Davis, E.J., et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37:Suppl. 1 (2014), S120–S143.